Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leukotriene C4 synthase (LTC4S) is a membrane-bound enzyme that catalyzes the conjugation of leukotriene A4 (LTA4) with reduced glutathione (GSH), producing leukotriene C4 (LTC4), the parent compound of the cysteinyl leukotrienes. These mediators play key roles in inflammatory responses, particularly in asthma and allergic reactions.
Catalyzes the conjugation of leukotriene A4 (LTA4) with reduced glutathione (GSH) to produce leukotriene C4 (LTC4).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leukotriene C4 Synthase (LTC4S).